tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
SURF is currently covered by 4 analysts with an average price target of $4.37. This is a potential upside of $3.3 (308.41%) from yesterday's end of day stock price of $1.07.
Surface Oncology's activity chart (see below) currently has 8 price targets and 13 ratings on display. The stock rating distribution of SURF is 71.43% BUY and 28.57% HOLD.
Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 90 days.
Highest price target for SURF is $1.15, Lowest price target is $1.15, average price target is $4.37.
Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 16-Jun-2023. First documented stock forecast 27-Aug-2020.
Currently out of the existing stock ratings of SURF, 5 are a BUY (71.43%), 2 are a HOLD (28.57%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1.15
$0.08 (7.48%)
3
10 months 4 days ago
1/6 (16.67%)
$0.36 (45.57%)
141
Buy
6
$4.93 (460.75%)
8.5
1 years 5 months 17 days ago
1/3 (33.33%)
$4.77 (387.80%)
129
Buy
6
$4.93 (460.75%)
17
1 years 5 months 17 days ago
0/2 (0%)
$4.77 (387.80%)
What is SURF (Surface Oncology) average time for price targets to be met?
Which analyst has the current highest performing score on SURF (Surface Oncology) with a proven track record?
Which analyst has the current lower performing score on SURF (Surface Oncology) with a proven track record?
Which analyst has the most public recommendations on SURF (Surface Oncology)?
Which analyst is the currently most bullish on SURF (Surface Oncology)?
Which analyst is the currently most reserved on SURF (Surface Oncology)?
